Related Experiment Video
Updated: Aug 14, 2026

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
[Zijin powder in inhibiting H22 mice solid and ascites liver cancer: experimental study]
Da-wen Wei1, Yu-mei Jia, Zhong-zheng Li
1Henan University of Traditional Chinese Medicine, Zhengzhou 450008, China.
Objective:
To observe the rate of Zijin powder in inhibiting H22 mice solid and ascites liver cancer and the relation between quatity and effect.
Method:
The Kunming mics, transplanted by H22 liver cells, were divided into a model group, a cyclophosphamide group and three groups of Zijin powder in high dose, medium dose, and low dose. Then observation was made on the rate of Cancer.
Result:
The inhibiting rates of Zijin powder of three groups (high dose group, medium dose group and low dose group) for H22 mice solid liver cancer were 30.8%, 38.31% and 48.59% respectivily. The inhibiting rates of three groups of Zijin powder (low dose group, medium dose and high dose group) for H22 mice ascites liver cancer were 6.77%, 15.59% and 14.90 % respectivily.
Conclusion:
Zijin powder has better effect on H22 mice solid liver cancer, and its effect is greatly increasing with the increased dosage.